TrialClinical research in cardiology : official journal of the German Cardiac Society2011

Intracoronary versus intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: 6-month effects on infarct size and left ventricular function. The randomised Leipzig Immediate PercutaneouS Coronary Intervention Abciximab i.v. versus i.c. in ST-Elevation Myocardial Infarction Trial (LIPSIAbciximab-STEMI).

Ingo Eitel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.